((2S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxytetrahydrofuran-2-yl)methyl (S)-2-hydroxy-4-methylpentanoylsulfamate

ID: ALA4441710

Chembl Id: CHEMBL4441710

PubChem CID: 155515577

Max Phase: Preclinical

Molecular Formula: C16H24N6O7S

Molecular Weight: 444.47

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)C[C@H](O)C(=O)NS(=O)(=O)OC[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)O1

Standard InChI:  InChI=1S/C16H24N6O7S/c1-8(2)3-10(23)15(25)21-30(26,27)28-5-9-4-11(24)16(29-9)22-7-20-12-13(17)18-6-19-14(12)22/h6-11,16,23-24H,3-5H2,1-2H3,(H,21,25)(H2,17,18,19)/t9-,10-,11+,16+/m0/s1

Standard InChI Key:  XJECSDUPPBMFLC-ZSYFIWHWSA-N

Alternative Forms

  1. Parent:

    ALA4441710

    ---

Associated Targets(Human)

LARS1 Tchem Leucyl-tRNA synthetase (173 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin mTORC2 (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 444.47Molecular Weight (Monoisotopic): 444.1427AlogP: -1.16#Rotatable Bonds: 8
Polar Surface Area: 191.78Molecular Species: ACIDHBA: 12HBD: 4
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.71CX Basic pKa: 4.92CX LogP: -2.25CX LogD: -1.87
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.38Np Likeness Score: 0.86

References

1. Yoon S, Kim SE, Kim JH, Yoon I, Tran PT, Ann J, Kim C, Byun WS, Lee S, Kim S, Lee J, Lee J..  (2019)  Structure-activity relationship of leucyladenylate sulfamate analogues as leucyl-tRNA synthetase (LRS)-targeting inhibitors of Mammalian target of rapamycin complex 1 (mTORC1).,  27  (6): [PMID:30755350] [10.1016/j.bmc.2019.01.037]

Source